ENLV (Enlivex Therapeutics Ltd) Company Book Value
The share price history of Enlivex Therapeutics (ENLV) reflects the dynamics of a company developing cell therapy to combat sepsis, with the indicator standing at 3.92. The production base relies on an Israeli high-tech complex featuring autonomous power supply and redundant filters. To accelerate drug registration, the business is implementing software robots for data processing and automated molecular screening stations.
%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_ENLV_-_Enlivex-Therapeutics_-_Company-Book-Value "ENLV Enlivex Therapeutics, Ltd. Net Asset Value (07/04/2022 - 10/30/2026) | 👁️GURU.Markets👁️")
ENLV (Enlivex Therapeutics, Ltd.): analytical breakdowns and indicator data
- share price and expert price forecast:
- business market valuation indicators:
- balance sheet net asset value indicators:
- debt and liquidity data:
Total Debt to Capital Enlivex Therapeutics|ENLV - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Enlivex Therapeutics|ENLV - Company Debts|Debt to Book Value Enlivex Therapeutics Ltd|ENLV - Company Long-Term Debts|Company Short-Term Debts Enlivex Therapeutics|Intermediate Coverage Ratio enlivex.com
- earnings and market ratios statistics:
Initial company analysis:Enlivex Therapeutics
The lack of operating cash flow at Enlivex Therapeutics (ENLV) leaves the company dependent on external financing for its clinical developments. The trend in the firm's book value of equity reflects the remaining net assets minus liabilities, allowing investors to assess the real value of the business and avoid overpaying for unjustified market expectations.
Competitor analysis for Enlivex Therapeutics
ARGX: Company Book Value|BNTX (BioNTech SE) - Company Net Assets|ABVX (ABIVAX) - Company Book Value|Company Book Value ADMA Biologics, Inc.|Protagonist Therapeutics, Inc. - Net Asset Value|Book Capitalization IMVT|KNSA (Kiniksa Corp) - Accounting Value of Company|Book Capitalization GRFS (Grifols, S.A.)|Book Capitalization adaptivebiotech.com ADPT|CLDX - Company Book Value|Accounting Value of Company AUPH (Aurinia Pharmaceuticals Inc)|BioCryst Pharmaceuticals Inc (BCRX) - Company Book Value|Company Net Assets Vera Corp|DNTH (Dianthus Therapeutics) - Book Capitalization|Book Capitalization pharvaris.com|Company Net Assets ABCL (AbCellera Bio)|TRML (Tourmaline Bio Inc) - Accounting Value of Company|Book Capitalization PGEN (Intrexon)|Book Valuation of Business Pharming Corp (PHAR)|NKTR - Company Book Value|upstreambio.com (UPB) - Company Net Assets|Zenas Biopharma (ZBIO) - Company Book Value|Company Net Assets Immunome Inc|Company Net Assets GOSS|Book Capitalization KalVista Corp|Company Book Value Septerna Inc (SEPN)|pieris.com - Accounting Capitalization|Book Capitalization SVRA (Savara)|Rigel Pharma (RIGL) - Total Stockholders' Equity|AnaptysBio Corp - Book Capitalization|Total Stockholders' Equity Astria Corp|enGene Holdings Inc. (ENGN) - Company Book Value|Accounting Capitalization RAPT|Company Book Value Aerovate Therapeutics, Inc.|Company Book Value ACRS|Book Capitalization KYTX|Book Valuation of Business Tiziana Life Sciences, Ltd.|Cabaletta Bio, Inc. - Company Net Assets|ventyxbio.com - Company Book Value|Theratechnologies - Book Capitalization|Total Stockholders' Equity Avalo Therapeutics, Inc.|ELDN (Eledon) - Company Net Assets|Accounting Capitalization AGEN|Company Net Assets CLYM|ZURA: Accounting Value of Company|Company Net Assets ATYR (aTyr Pharma)|Total Net Assets ADAG|Book Capitalization IMA (Ikena Oncology)|Accounting Value of Company STTK|Equillium Bio - Book Capitalization|Total Stockholders' Equity Connect Biopharma|immunic-therapeutics.com (IMUX) - Company Book Value|Atara Bio - Accounting Value of Company|IFRX (InflaRx NV) - Book Capitalization|Book Capitalization X4 Pharmaceuticals, Inc|Company Book Value Adicet Bio (ACET)|CELU: Net Asset Value|Book Capitalization INMB (INmune Bio)|Barinthus Biotherapeutics PLC (BRNS) - Total Stockholders' Equity|KZR: Company Net Assets|SABS - Book Capitalization|AKTX (Akari Therapeutics) - Company Net Assets|QTTB: Total Net Assets|GOVX (GeoVax) - Book Capitalization|Edesa Biotech Inc (EDSA) - Book Valuation of Business|Book Capitalization IBIO|Company Net Assets carismatx.com CARM|Company Book Value XTL Biopharmaceuticals XTLB|Book Valuation of Business Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics Inc - Book Capitalization|Total Stockholders' Equity Aptevo Therapeutics|AIM ImmunoTech (AIM) - Company Book Value|Accounting Capitalization ADTX|Company Book Value GRI Bio, Inc.|Company Book Value XRTX|Company Net Assets HIND (Vyome Holdings)|Company Book Value REVB (Revelation Biosciences Inc)|Company Book Value Indaptus INDP|SCNI (BiondVax Pharmaceuticals) - Net Asset Value|CalciMedica Corp - Book Capitalization|Accounting Value of Company AFMD (Affimed)|ALLK: Book Capitalization|HOOKIPA Pharma (HOOK) - Book Capitalization|Company Book Value IGM Biosciences Inc.|ITOS: Accounting Value of Company|Company Book Value Ocean Biomedical, Inc. (OCEA)|Company Net Assets tcbiopharm.com TCBP|Book Capitalization THRD (Third Harmonic Bio, Inc.)